Cortical Thickness Change
Introduction
Cortical thickness refers to the depth of the cerebral cortex, the outermost layer of the brain, which is fundamental for higher cognitive functions such as memory, attention, perception, thought, language, and consciousness. Changes in cortical thickness are a dynamic process that occurs throughout an individual's lifespan, influenced by a complex interplay of genetic predispositions, environmental factors, and lifestyle choices.
Biological Basis
The cerebral cortex undergoes significant development from childhood through adolescence, reaching peak thickness in early adulthood, followed by a gradual thinning process with aging. These changes reflect intricate biological processes, including alterations in neuronal size and density, synaptic pruning, myelination, and neurogenesis. Genetic factors are known to play a substantial role in determining an individual's baseline cortical thickness and the trajectory of its changes over time.
Clinical Relevance
Variations and changes in cortical thickness are critically associated with a wide array of neurological and psychiatric conditions. For instance, abnormal thinning of specific cortical regions is a hallmark of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Cortical thickness changes are also implicated in psychiatric disorders like schizophrenia, depression, and anxiety, as well as developmental disorders such as autism spectrum disorder. Consequently, cortical thickness serves as a valuable biomarker for disease onset, progression, treatment response, and risk stratification in clinical settings.
Social Importance
Understanding the factors that influence cortical thickness change holds significant social importance. Research in this area can lead to the development of earlier diagnostic tools, more targeted and effective therapeutic interventions, and personalized medicine approaches for individuals affected by brain disorders. Furthermore, insights into how lifestyle and environmental factors impact cortical thickness contribute to broader public health strategies aimed at promoting brain health, preventing cognitive decline, and improving the overall quality of life across the lifespan.
Methodological and Statistical Constraints
Research into cortical thickness is subject to several methodological and statistical limitations inherent in large-scale genetic studies. A primary concern is the limited statistical power to detect genetic variants with modest effects, particularly given the extensive multiple testing corrections required in genome-wide association studies (GWAS). [1] This means that many true associations explaining a small proportion of phenotypic variation might remain undetected, leading to an incomplete understanding of the genetic architecture of cortical thickness. [1] Furthermore, the use of array-based genotyping platforms often provides only partial coverage of genetic variation, potentially missing causal variants not present on the chip or those in weak linkage disequilibrium with genotyped markers. [1]
Replication of findings across different cohorts can also be challenging due to differences in study design, statistical power, and the specific single nucleotide polymorphisms (SNPs) genotyped. [2] Non-replication at the SNP level does not always imply a false positive, as different studies might identify distinct SNPs in strong linkage disequilibrium with an unobserved causal variant, or reflect multiple causal variants within the same gene region. [2] Additionally, while efforts are made to control for population stratification, analytical approaches that do not use family-based designs are not entirely immune to its effects, which could lead to spurious associations if not adequately addressed. [3] The choice of statistical models, such as assuming an additive inheritance pattern, may also oversimplify complex genetic architectures and miss non-additive effects. [4]
Phenotypic Definition and Measurement Variability
The precise definition and measurement of cortical thickness present significant challenges that can impact the interpretation of genetic findings. For instance, studies that average phenotypic traits over extended periods, sometimes spanning decades, may inadvertently mask age-dependent genetic effects. [1] This averaging strategy also assumes that the underlying genetic and environmental factors influencing the trait remain consistent across wide age ranges, an assumption that may not hold true. [1] Moreover, the use of different measurement equipment or protocols over time can introduce misclassification and variability, further complicating the accurate characterization of cortical thickness. [1]
These measurement inconsistencies can introduce noise into the data, potentially attenuating true genetic signals or leading to spurious associations. The long-term stability of cortical thickness measurements and the potential for regression dilution bias, while sometimes addressed, remain critical considerations. [1] Therefore, variations in how cortical thickness is assessed and averaged across studies or within longitudinal cohorts can significantly influence the detected genetic associations and their apparent effect sizes, highlighting the need for highly standardized and consistent phenotyping approaches.
Generalizability and Unaccounted Influences
A substantial limitation in genetic studies of cortical thickness relates to the generalizability of findings and the potential impact of unmeasured confounding factors. Many large-scale genetic studies, including those informing our understanding of cortical thickness, have predominantly involved cohorts of European descent. [1] This demographic bias means that the applicability of identified genetic variants and their effect sizes to other ancestral populations remains largely unknown, limiting the broader utility of these findings. [1] Genetic effects can be context-specific, and variant frequencies and their functional impacts may differ significantly across diverse populations.
Furthermore, the influence of environmental factors and gene-environment interactions on cortical thickness is often not comprehensively investigated, yet these can profoundly modulate genetic effects. [1] For example, specific environmental exposures or lifestyle factors could alter how certain genetic variants manifest phenotypically, and the absence of such analyses means these crucial interactions are missed. [1] Similarly, analyses that pool sexes without investigating sex-specific effects may overlook genetic variants that influence cortical thickness differently in males and females, thereby providing an incomplete picture of the trait's genetic underpinnings. [5] Addressing these gaps is crucial for a more complete and universally applicable understanding of cortical thickness.
Variants
Genetic variations play a crucial role in shaping brain structure and function, including cortical thickness, a key indicator of brain health and cognitive abilities. Several single nucleotide polymorphisms (SNPs) and their associated genes have been identified as potential contributors to these complex traits. These genes are often involved in fundamental biological processes such as neuronal development, cell signaling, and gene regulation, which are critical for the formation and maintenance of cortical architecture.
Genes involved in neuronal structure and development include _CSMD1_ and _EPHA7_. _CSMD1_ (CUB and Sushi Multiple Domains 1) is a large gene implicated in neurodevelopmental processes and synaptic function, with variants like *rs75595201* potentially influencing its expression or protein activity. Such alterations could impact cortical development and the intricate network of neuronal connections. Similarly, _EPHA7_ (Ephrin Receptor A7) encodes a receptor crucial for guiding axons during neural circuit formation and regulating synaptic plasticity in the adult brain. A variant such as *rs564158* could disrupt these precise developmental processes, leading to measurable changes in cortical thickness, which reflects the density of neuronal cell bodies and their extensions. Furthermore, _GAP43_ (Growth Associated Protein 43) is essential for axon growth, regeneration, and synaptic plasticity, and the pseudogene EIF4E2P2 is linked to its regulatory network. A variant like *rs1438361* could affect the regulation of _GAP43_ or other related genes vital for neural development and the maintenance of cortical structure, which are often investigated through large-scale genetic studies. [6] These types of genetic variations are broadly associated with various complex phenotypes, including those influencing brain health and its structural integrity .
Other genetic factors contribute through gene regulation and cellular processes. PITX1-AS1 is a long non-coding RNA (lncRNA) that acts as an antisense regulator for _PITX1_, a transcription factor critical for cell differentiation and organogenesis, including aspects of brain development. The variant *rs595269* might influence the stability or regulatory function of PITX1-AS1, thereby modulating _PITX1_ expression and potentially affecting cortical development and neuronal connectivity. _MITF_ (Melanocyte Inducing Transcription Factor) is a master regulator of cell differentiation, while FRMD4B is involved in cell adhesion and signaling. Variants such as *rs138245526* in this region could impact cellular processes vital for neuronal organization and the integrity of cortical layers. Additionally, _MIR3166_ is a microRNA that regulates gene expression, and its associated gene _CTSC_ (Cathepsin C) encodes a lysosomal protease involved in protein degradation and immune responses, which can indirectly influence neuronal health. A variant like *rs17809993* could alter _MIR3166_ function or _CTSC_ expression, impacting cellular homeostasis and potentially contributing to changes in cortical thickness . These fundamental cellular and regulatory mechanisms are frequently explored in extensive genetic studies that examine a broad spectrum of human traits. [4]
Further contributing to brain architecture are genes involved in cell polarity and metabolic regulation. _PARD3B_ (Par-3 Family Cell Polarity Regulator Beta) is a crucial protein for establishing cell polarity, a fundamental process for neuronal migration, differentiation, and tissue organization during brain development. The variant *rs6435231*, located near _PARD3B_ or its pseudogene DSTNP5, might influence these critical developmental steps, affecting the precise arrangement of neurons and ultimately cortical thickness. _CCDC50_ (Coiled-Coil Domain Containing 50) is involved in various cellular functions, including signal transduction and protein interactions, which are essential for neuronal communication and maintenance. PYDC2-AS1 is an antisense RNA that could modulate _CCDC50_ expression. A variant such as *rs143400904* could alter these regulatory mechanisms, impacting cellular function and neuronal integrity. Additionally, _LYPD6_ (LY6/PLAUR Domain Containing 6) encodes a GPI-anchored protein important for cell surface interactions and signaling, while its association with _MMADHC_ (Methylmalonic Aciduria And Homocystinuria Type C Protein) highlights a connection to broader cellular metabolism, particularly vitamin B12 processing, which is vital for brain health. The variant *rs34940387* might influence these complex pathways, thereby contributing to variations in cortical thickness. [6] Moreover, long intergenic non-coding RNAs like LINC02291 and LINC02312, with variants such as *rs72698183*, can exert regulatory control over nearby genes, impacting neural development and contributing to individual differences in brain morphology. [4]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs75595201 | LINC03021 - CSMD1 | cortical thickness change measurement |
| rs595269 | PITX1-AS1 | cortical thickness change measurement |
| rs138245526 | FRMD4B - MITF | cortical thickness change measurement |
| rs6435231 | DSTNP5 - PARD3B | cortex volume change measurement cortical thickness change measurement |
| rs17809993 | MIR3166 - CTSC | total brain volume change measurement, age at assessment cortex volume change measurement, age at assessment cortical thickness change measurement |
| rs1438362 | EIF4E2P2 - GAP43 | cortical thickness change measurement |
| rs72698183 | LINC02291 - LINC02312 | cortical thickness change measurement |
| rs564158 | EPHA7 | cortical thickness change measurement |
| rs34940387 | LYPD6 - MMADHC | cortical thickness change measurement |
| rs143400904 | CCDC50 - PYDC2-AS1 | cortical thickness change measurement |
Biological Background
The thickness of biological tissues is a dynamic trait influenced by a complex interplay of molecular, cellular, and genetic factors, often reflecting underlying physiological states or pathological processes. Changes in tissue thickness can serve as crucial indicators of health and disease, with implications for tissue function and overall systemic well-being. Understanding the biological mechanisms driving these structural alterations provides insight into disease pathogenesis and potential therapeutic targets.
Cellular and Molecular Pathways in Tissue Remodeling
Cellular functions and metabolic processes are fundamental to maintaining and altering tissue structure. Endothelial function, for instance, plays a critical role in the integrity of blood vessel walls, with endothelial dysfunction serving as an early and fundamental component in the development of atherosclerosis, a condition characterized by arterial wall thickening. [1] This dysfunction can precede overt cardiovascular disease, indicating its importance in the initial stages of structural tissue changes.
Key biomolecules, such as lipids and uric acid, and the enzymes that regulate their metabolism, significantly impact tissue health and structure. For example, common single nucleotide polymorphisms (SNPs) in the HMGCR gene, which encodes a critical enzyme in cholesterol synthesis, can affect alternative splicing of exon13 and are associated with levels of LDL-cholesterol. [7] Similarly, the GLUT9 gene is associated with serum uric acid levels. [8] Disruptions in these metabolic pathways and the associated regulatory networks can contribute to abnormal tissue remodeling and thickening.
Genetic Architecture of Tissue Structural Traits
Genetic mechanisms exert a substantial influence on the structural characteristics of tissues, including their thickness. Studies have demonstrated that traits such as left ventricular chamber size and wall thickness, as well as carotid artery intimal medial thickness, are heritable. [1] These heritable traits have been linked to specific genetic loci, suggesting that variations in an individual's genome contribute to differences in tissue architecture.
Genome-wide association studies have identified numerous genetic variants that influence intermediate phenotypes, providing insights into potentially affected biological pathways. [9] For instance, specific loci have been identified that influence lipid concentrations, which are known risk factors for coronary artery disease and, by extension, arterial wall thickening. [10] Furthermore, common variants across 30 loci have been found to contribute to polygenic dyslipidemia, a condition impacting lipid metabolism and indirectly influencing tissue structures susceptible to lipid accumulation. [4]
Pathophysiological Processes Underlying Tissue Thickening
Changes in tissue thickness are often central to various pathophysiological processes and disease mechanisms. The thickening of the left ventricular wall, known as left ventricular remodeling, and increased left ventricular mass are fundamental to the pathogenesis of high blood pressure, clinical cardiovascular disease (CVD), stroke, and heart failure. [1] These structural changes represent compensatory responses to chronic stress, such as hypertension, but can ultimately lead to impaired organ function and disease progression.
Similarly, the thickening of carotid artery walls, quantified by measures such as intimal medial thickness (IMT), is a hallmark of subclinical atherosclerosis, a disease mechanism affecting major arterial territories. [6] This progressive thickening results from complex interactions between inflammation, lipid deposition, and cellular proliferation within the arterial wall. These homeostatic disruptions, if unchecked, can lead to severe systemic consequences, including reduced blood flow and increased risk of cardiovascular events.
Systemic Biomarkers and Tissue Interactions
Tissue structural changes are often interconnected with broader systemic biology, reflected in various circulating biomarkers. Intermediate phenotypes, such as metabolite profiles in human serum, can offer detailed insights into affected pathways related to tissue changes. [9] These profiles can reveal metabolic imbalances that contribute to or result from alterations in tissue thickness.
Beyond metabolites, other key biomolecules like proteins, enzymes, and hormones serve as important indicators and mediators of tissue remodeling. Protein quantitative trait loci (pQTLs) have been identified, indicating genetic influences on protein levels that could, in turn, affect cellular functions and structural components within tissues. [11] Furthermore, plasma levels of liver enzymes, hemostatic factors, and hematological phenotypes have been linked through genome-wide association studies, demonstrating how systemic factors and their genetic regulation can influence overall physiological states that impact tissue integrity and thickness throughout the body . [5], [12]
References
[1] Vasan, R.S. et al. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Med Genet, 2007.
[2] Sabatti, Chiara, et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nature Genetics, vol. 41, no. 1, 2009, pp. 35-42. PMID: 19060910.
[3] Uda, Manuela, et al. "Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia." Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, 2008, pp. 1620-1625. PMID: 18245381.
[4] Kathiresan, S. et al. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, 2008.
[5] Yang, Q. et al. "Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study." BMC Med Genet, 2007.
[6] O'Donnell, C.J. et al. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Med Genet, 2007.
[7] Burkhardt, R. et al. "Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13." Arterioscler Thromb Vasc Biol, 2008.
[8] Li, S. et al. "The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts." PLoS Genet, 2007.
[9] Gieger, C. et al. "Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum." PLoS Genet, 2008.
[10] Willer, C.J. et al. "Newly identified loci that influence lipid concentrations and risk of coronary artery disease." Nat Genet, 2008.
[11] Melzer, D. et al. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genet, 2008.
[12] Yuan, X. et al. "Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes." Am J Hum Genet, 2008.